Preventive and Alleviative Effect of Tramadol on Neuropathic Pain in Rats: Roles of α2-Adrenoceptors and Spinal Astrocytes

被引:26
作者
Sakakiyama, Minoru [1 ]
Maeda, Sanae [1 ]
Isami, Kouichi [1 ]
Asakura, Kayoko [1 ]
So, Kanako [1 ]
Shirakawa, Hisashi [1 ]
Nakagawa, Takayuki [1 ,2 ]
Kaneko, Shuji [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Sakyo Ku, Kyoto 6068507, Japan
关键词
tramadol; neuropathic pain; antidepressant; alpha(2)-adrenoceptor; astrocyte; RELIEVES THERMAL HYPERALGESIA; NEUROIMMUNE ACTIVATION; ABNORMAL PAIN; NERVE INJURY; MODEL; AMITRIPTYLINE; MORPHINE; ANTIDEPRESSANTS; CORD; BETA(2)-ADRENOCEPTORS;
D O I
10.1254/jphs.13223FP
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The acute analgesic effect of tramadol has been extensively investigated; however, its long-term effect on neuropathic pain has not been well clarified. In this study, we examined the effects of repeated administration of tramadol on partial sciatic nerve ligation-induced neuropathic pain in rats. Each drug was administered once daily from 0 - 6 days (preventive effect) or 7 - 14 days (alleviative effect) after the surgery. Mechanical allodynia was evaluated just before (preventive or alleviative effect) and 1 h after (analgesic effect) drug administration. Like morphine, first administration of tramadol (20 mg/kg) showed an acute analgesic effect on the developed mechanical allodynia, which was diminished by naloxone. Like amitriptyline, repeated administration of tramadol showed preventive and alleviative effects on the mechanical allodynia that was diminished by yohimbine, but not naloxone. The alleviative effects of tramadol lasted even after drug cessation or in the presence of yohimbine. Repeated administration of tramadol increased the dopamine beta-hydroxylase immunoreactivity in the spinal cord. Furthermore, tramadol inhibited the nerve ligation-induced activation of spinal astrocytes, which was reduced by yohimbine. These results suggest that tramadol has both mu-opioid receptor mediated acute analgesic and alpha(2)-adrenoceptor-mediated preventive and alleviative effects on neuropathic pain, and the latter is due to alpha(2)-adrenoceptor-mediated inhibition of astrocytic activation.
引用
收藏
页码:244 / 257
页数:14
相关论文
共 66 条
  • [61] Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance
    Vanderah, TW
    Suenaga, NMH
    Ossipov, MH
    Malan, TP
    Lai, J
    Porreca, F
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (01) : 279 - 286
  • [62] The "Toll" of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia
    Watkins, Linda R.
    Hutchinson, Mark R.
    Rice, Kenner C.
    Maier, Steven F.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (11) : 581 - 591
  • [63] Evidence for suppression of spinal glial activation by dexmedetomidine in a rat model of monoarthritis
    Xu, Bo
    Zhang, Wei-Shi
    Yang, Jia-Le
    Lu, Ning
    Deng, Xiao-Ming
    Xu, Hua
    Zhang, Yu-Qiu
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (10): : e158 - e166
  • [64] β2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain
    Yalcin, Ipek
    Tessier, Luc-Henri
    Petit-Demouliere, Nathalie
    Doridot, Stephane
    Hein, Lutz
    Freund-Mercier, Marie-Jose
    Barrot, Michel
    [J]. NEUROBIOLOGY OF DISEASE, 2009, 33 (03) : 386 - 394
  • [65] β2-Adrenoceptors Are Critical for Antidepressant Treatment of Neuropathic Pain
    Yalcin, Ipek
    Choucair-Jaafar, Nada
    Benbouzid, Malika
    Tessier, Luc-Henri
    Muller, Andre
    Hein, Lutz
    Freund-Mercier, Marie-Jose
    Barrot, Michel
    [J]. ANNALS OF NEUROLOGY, 2009, 65 (02) : 218 - 225
  • [66] Tramadol reinforces antidepressant effects of ketamine with increased levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in rat hippocampus
    Yang C.
    Li X.
    Wang N.
    Xu S.
    Yang J.
    Zhou Z.
    [J]. Frontiers of Medicine, 2012, 6 (4) : 411 - 415